CausalSentinel

Protein Dossier — CST6 (Cystatin-M)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Alcohol intake frequency 0.0572 0.019 0.00255 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension 0.0609 0.0206 0.0031 Wald ratio 1 cis NA
Forearm bone mineral density -0.226 0.0809 0.00513 Wald ratio 1 cis NA
Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0915 0.0355 0.01 Wald ratio 1 cis NA
Pallidum volume -23.7 10.5 0.0238 Wald ratio 1 cis NA
Diagnoses - main ICD10: H25 Senile cataract 0.256 0.115 0.0264 Wald ratio 1 cis NA
Hip osteoarthritis 0.32 0.144 0.027 Wald ratio 1 cis NA
Knee and hip osteoarthritis 0.249 0.113 0.0284 Wald ratio 1 cis NA
Diagnoses - main ICD10: K40 Inguinal hernia -0.215 0.0984 0.0288 Wald ratio 1 cis NA
ER-positive Breast cancer (Combined Oncoarray; iCOGS; GWAS meta analysis) 0.0894 0.0427 0.0366 Wald ratio 1 cis NA
Primary sclerosing cholangitis -0.343 0.168 0.0408 Wald ratio 1 cis NA
Diagnoses - main ICD10: N20 Calculus of kidney and ureter 0.238 0.123 0.0522 Wald ratio 1 cis NA
…and 70 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3303_23_2 Cystatin M Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

17 association rows across 15 traits (16 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Cystatin-M (analyte X3303.23) levels 4e-281 rs1131544 1 GCST90425683 no MR -> candidate analysis
Cystatin-M (analyte X14711.27) levels 1e-275 rs1131544 1 GCST90422581 no MR -> candidate analysis
Cerebrospinal fluid protein CST6 levels 1e-250 rs1131544 1 GCST90944731 no MR -> candidate analysis
CST6 protein levels 4e-206 rs12576095 1 GCST90468896 no MR -> candidate analysis
Serum levels of protein CST6 1e-17 rs72930985 1 GCST90087915 no MR -> candidate analysis
Waist circumference adjusted for body mass index 3e-15 rs12785292 1 GCST90020029 no MR -> candidate analysis
Height 2e-14 rs684546 3 GCST008839 no MR -> candidate analysis
Serum uric acid levels 2e-11 rs76541013 1 GCST010512 no MR -> candidate analysis
Multi-trait sex score 1e-10 rs12785292 1 GCST90270116 no MR -> candidate analysis
Waist-hip index 4e-10 rs12785292 1 GCST90020027 no MR -> candidate analysis
A body shape index 1e-9 rs12785292 1 GCST90020024 no MR -> candidate analysis
Alzheimer’s disease 1e-9 rs12785292 1 GCST90134416 MR: beta=0.116, p=0.156 (cis)
…and 3 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1581 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
autosomal recessive hypohidrotic ectodermal dysplasia 0.555 established (curated) no MR -> candidate analysis
total hip arthroplasty 0.313 common-variant locus no MR -> candidate analysis
osteoarthritis, hip 0.313 common-variant locus MR: beta=0.32, p=0.027 (cis)

Of the 3 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (Cystatin-B)
gnomAD constraint pLI=0.0051, LOEUF=1.34 — LoF-tolerant
GWAS Catalog 79 unique SNPs / 158 rows
ClinVar 44 records; 4 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance